Volume 84, Issue 5
Original article

Resolution of HLA‐B*44:02:01G, ‐DRB1*14:01:01G and ‐DQB1*03:01:01G reveals a high allelic variability among 12 European populations

B. Vidan‐Jeras

Tissue Typing Center, Blood Transfusion Center of Slovenia, Ljubljana, Slovenia

Search for more papers by this author
S. Buhler

Laboratory of Anthropology, Genetics and Peopling History, Department of Genetics and Evolution – Anthropology Unit and Institute of Genetics and Genomics in Geneva (IGE3), University of Geneva, Geneva, Switzerland

Search for more papers by this author
V. Dubois

Etablissement Français du Sang (EFS) Rhône‐Alpes, Laboratoire HLA, Lyon, France

Search for more papers by this author
Z. Grubic

Tissue Typing Centre, University Hospital Centre Zagreb, Zagreb, Croatia

Search for more papers by this author
M. Ivanova

Department of Clinical Immunology, University Hospital Alexandrovska, Sofia, Bulgaria

Search for more papers by this author
T. Jaatinen

Finnish Red Cross Blood Service, Clinical Laboratory, Helsinki, Finland

Search for more papers by this author
D. Ligeiro

Centro de Histocompatibilidad do Sul, Instituto Português de Sangue e Transplantaçâo, Lisbon, Portugal

Search for more papers by this author
M.‐L. Lokki

Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland

Search for more papers by this author
C. Papasteriades

Department of Immunology and Histocompatibility, Evangelismos Hospital, Athens, Greece

Search for more papers by this author
F. Poli

Organ and Tissue Transplantation Immunology, Regenerative Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Search for more papers by this author
M. Spyropoulou‐Vlachou

Immunology Department – Tissue Typing Laboratory, General University Hospital of Athens Alexandra, Athens, Greece

Search for more papers by this author
A. Tordai

Hungarian National Blood Transfusion Center, Transplantation Immunogenetics Laboratory, Budapest, Hungary

Search for more papers by this author
M.K. Viken

Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway

Search for more papers by this author
S. Wenda

Department for Blood Group Serology, Medical University Vienna, Wien, Austria

Search for more papers by this author
J.M. Nunes

Laboratory of Anthropology, Genetics and Peopling History, Department of Genetics and Evolution – Anthropology Unit and Institute of Genetics and Genomics in Geneva (IGE3), University of Geneva, Geneva, Switzerland

Search for more papers by this author
A. Sanchez‐Mazas

Laboratory of Anthropology, Genetics and Peopling History, Department of Genetics and Evolution – Anthropology Unit and Institute of Genetics and Genomics in Geneva (IGE3), University of Geneva, Geneva, Switzerland

Search for more papers by this author
J.‐M. Tiercy

Corresponding Author

National Reference Laboratory for Histocompatibility, University Hospital Geneva, Geneva, Switzerland

Correspondence

Dr Jean‐Marie Tiercy

National Reference Laboratory for Histocompatibility

Transplantation Immunology Unit

Department of Genetics and Laboratory Medicine and Department of Medical Specialties

Geneva University Hospitals and University of Geneva

4 rue Gabrielle‐Perret‐Gentil

1211 Geneva 14

Switzerland

Tel: +41 22 3729401

Fax: +41 22 3729390

e‐mail: jean-marie.tiercy@unige.ch

Search for more papers by this author
First published: 11 September 2014
Citations: 5

Abstract

Within the framework of the EU‐funded HLA‐NET action, an analysis of three G‐group alleles, HLA‐B*44:02:01G, DRB1*14:01:01G and DQB1*03:01:01G, was undertaken in 12 European populations. Ambiguities were resolved by polymerase chain reaction‐sequence‐specific amplification (PCR‐SSP) or PCR‐sequence‐based typing (PCR‐SBT) in a total of 5095 individuals. The results of the DRB1*14:01/14:54 ambiguity showed high relative ratios (24–53%) of DRB1*14:01 in Bulgarians, Croatians, Greeks, Italians and Slovenians, contrasting with low ratios (6–13%) in Austrians, Finnish, French, Hungarians, Norwegians and Swiss. Resolution of the B*44:02/44:27 ambiguity showed that B*44:27 had a high relative ratio in Slovenians (25.5%) and Bulgarians (37%) and low in French and Swiss (0.02–1%), and was not observed in Greeks and Italians. The highest relative ratio of DQB1*03:19 was found in Portuguese (11%), by contrast with low ratios (0–3%) in the other five populations. Analysis of the A, B, DRB1 phenotypes and family‐derived haplotypes in 1719 and 403 individuals positive for either HLA‐B*44:02G or DRB1*14:01G ambiguities, respectively, showed some preferential associations, such as A*26∼DRB1*14:01, B*35∼DRB1*14:01, B*38∼DRB1*14:01 and B*44:27∼DRB1*16. Because these ambiguities are located outside the peptide‐binding site, they may not be recognized by alloreactive T‐cells. However, because of strong linkage disequilibrium (LD), the DRB1*14:01 vs DRB1*14:54 and the B*44:02 vs B*44:27 mismatches are associated to DRB3‐, and C‐mismatches, respectively. These results are informative for algorithms searching unrelated hematopoietic stem cell donors. For B*44:27‐positive patients, searches are expected to be more successful when requesting donors from Southeastern‐European ancestry. Furthermore, the introduction of human leukocyte antigen (HLA)‐typing strategies that allow resolving exon 4 (for class I) and exon 3 (for class II) polymorphisms can be expected to contribute significantly to population genetics studies.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.